CTSF Gene (CLN10)

CTSF Gene (CLN10)

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CTSF — Cathepsin F</th>
</tr>
<tr> [@lysosomal]
<td class="label">Symbol</td>
<td><strong>CTSF</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Cathepsin F</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>11q13.2</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/8722" target="_blank">8722</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000174080" target="_blank">ENSG00000174080</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/608536" target="_blank">608536</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q9UJW0" target="_blank">Q9UJW0</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Neuronal Ceroid Lipofuscinosis](/diseases/ceroid-lipofuscinosis) (CLN10)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Cerebral [cortex](/brain-regions/cortex), Cerebellum, Lysosomal tissues</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

CTSF — Cathepsin F (CLN10)

Introduction

CTSF Gene (CLN10)

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CTSF — Cathepsin F</th>
</tr>
<tr> [@lysosomal]
<td class="label">Symbol</td>
<td><strong>CTSF</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Cathepsin F</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>11q13.2</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/8722" target="_blank">8722</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000174080" target="_blank">ENSG00000174080</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/608536" target="_blank">608536</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q9UJW0" target="_blank">Q9UJW0</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Neuronal Ceroid Lipofuscinosis](/diseases/ceroid-lipofuscinosis) (CLN10)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Cerebral [cortex](/brain-regions/cortex), Cerebellum, Lysosomal tissues</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

CTSF — Cathepsin F (CLN10)

Introduction

CTSF (Cathepsin F) is a gene located on chromosome 11q13.2 that encodes a lysosomal cysteine protease of the papain family. It is catalogued as NCBI Gene ID [8722](https://www.ncbi.nlm.nih.gov/gene/8722) and OMIM [608536](https://omim.org/entry/608536). Mutations in CTSF cause CLN10 disease, a severe form of neuronal ceroid lipofuscinosis (Batten disease) characterized by early-onset neurodegeneration.

The protein encoded by CTSF is [CTSF Protein](/proteins/ctsf-protein).[@ctsf]

Overview

Cathepsin F is a lysosomal cysteine protease that plays a critical role in intracellular protein degradation. As a member of the cathepsin family, CTSF participates in the breakdown of proteins within lysosomes, a process essential for cellular homeostasis and neuronal survival.

CLN10 disease caused by CTSF mutations is one of the most severe forms of neuronal ceroid lipofuscinosis, with symptoms manifesting in infancy or early childhood. The disease involves progressive loss of neuronal function, visual impairment, seizures, and premature death.[@neuronal]

Function

Enzymatic Activity

CTSF encodes a lysosomal cysteine protease with endopeptidase activity. The protein is synthesized as a preproenzyme and processed to its active form within lysosomes. Cathepsin F belongs to the papain family (C1 family) of cysteine proteases and shares structural homology with other cathepsins (B, L, S, K).[@cathepsin]

Protein Structure

The CTSF protein contains:

• Signal peptide for targeting to the endoplasmic reticulum
• Propeptide region that inhibits activity until lysosomal activation
• Mature catalytic domain with the characteristic cysteine protease active site

Lysosomal Function

Within lysosomes, CTSF participates in:

• Protein degradation: Cleaves various protein substrates for recycling
• [Autophagy](/entities/autophagy): Contributes to autophagic flux and clearance of cellular debris
• Lipid metabolism: Helps process lipids associated with ceroid deposits

Brain Expression and Localization

Regional Expression

CTSF is expressed in multiple brain regions:

• Cerebral cortex: Particularly layer 5 pyramidal [neurons](/entities/neurons)
• Cerebellum: Purkinje cells and granule cells
• [Hippocampus](/brain-regions/hippocampus): Dentate gyrus and CA regions
• Substantia nigra: Dopaminergic neurons

Cellular Localization

In neurons, CTSF localizes to:

• Lysosomes throughout the soma and dendrites
• Autophagosomes during autophagy
• Synaptic vesicles in presynaptic terminals

Disease Associations

CLN10 Disease (Neuronal Ceroid Lipofuscinosis Type 10)

CLN10 is caused by recessive mutations in CTSF, leading to deficiency of cathepsin F enzymatic activity. This results in accumulation of ceroid lipofuscins—lipopigments composed of lipids and proteins—in lysosomes throughout the body, particularly in neurons.

Clinical Features:

• Early-onset severe neurodegeneration (infantile form)
• Developmental regression
• Seizures
• Visual impairment (retinal degeneration)
• Microcephaly
• Premature death

• Null mutations: Severe infantile onset
• Missense mutations: Later onset, slower progression

Relationship to Other Neurodegenerative Diseases

While primarily associated with CLN10, CTSF dysfunction may contribute to:

• [Alzheimer's disease](/diseases/alzheimers-disease): Altered lysosomal function affects amyloid processing
• [Parkinson's disease](/diseases/parkinsons-disease): Autophagy-lysosome pathway dysfunction
• General aging: Declining lysosomal function contributes to neurodegeneration

Pathogenic Mechanisms

Lysosomal Storage

Loss of CTSF function leads to accumulation of:

• Lipofuscin-like ceroid deposits
• Mitochondrial components
• Protein aggregates
• Cellular debris

Autophagy Dysfunction

CTSF deficiency impairs autophagic flux:

• Reduced clearance of damaged organelles
• Accumulation of defective mitochondria
• Impaired protein quality control

Apoptosis

Neuronal loss in CLN10 involves:

• Mitochondrial dysfunction
• Oxidative stress
• Activation of apoptotic pathways
• Caspase-dependent cell death

Therapeutic Approaches

Enzyme Replacement Therapy

Recombinant cathepsin F delivery through:

• Intravenous enzyme replacement
• Direct CNS delivery (intrathecal, intraventricular)
• Enzyme transport across the [blood-brain barrier](/entities/blood-brain-barrier) using receptor-mediated systems

Gene Therapy

AAV-mediated CTSF delivery approaches:

• AAV9 vectors targeting neurons
• Promoter selection for neuronal specificity
• Dose optimization for efficacy and safety

Small Molecule Therapy

Pharmacological approaches:

• Proteostasis modulators
• Lysosomal function enhancers
• Autophagy inducers

Newborn Screening

CTSF activity can serve as a biomarker:

• Dried blood spot testing
• Early detection enables pre-symptomatic treatment
• Enzyme activity measurement

Research Models

Animal Models

• Ctsf knockout mice: Recapitulate key features of CLN10
• Zebrafish models: Useful for developmental studies

Cell Models

• Patient-derived iPSCs: Differentiated neurons for disease modeling
• Fibroblast cultures: For enzyme activity studies

Diagnostic Testing

Genetic Testing

• Sequence analysis of CTSF coding regions
• Deletion/duplication analysis
• Newborn screening programs

Biochemical Testing

• Cathepsin F activity assays
• Lysosomal enzyme panels
• Biomarker analysis (fingolimod, SAPs)

Clinical Diagnosis

• Neurological examination
• Visual field testing
• EEG monitoring
• MRI brain imaging

See Also

• [Lysosomal Storage Disorders](/diseases/lysosomal-storage-disorders)
• [Neuronal Ceroid Lipofuscinoses](/diseases/neuronal-ceroid-lipofuscinoses)
• [Cathepsins](/proteins/cathepsin-family)
• [CLN10 Disease](/diseases/cln10)
• [Infantile Neurodegeneration](/diseases/infantile-neurodegeneration)
• [Gene Therapy Approaches](treatments/gene-therapy)
• [Enzyme Replacement Therapy](/therapeutics/enzyme-replacement-therapy)

External Links

• [CTSF Gene - NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/8722)
• [CTSF Protein - UniProt](https://www.uniprot.org/uniprot/Q9UJW0)
• [CLN10 - OMIM](https://omim.org/entry/608536)
• [CTSF Gene - GeneCards](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CTSF)
• [CTSF Gene - HGNC](https://www.genenames.org/data/hgnc_data.php?appid=2&request_id=2)
• [CLN10 Disease - GeneReviews](https://www.ncbi.nlm.nih.gov/books/NBK1116/)
• [CTSF Gene - Ensembl](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000139651)

Background

The study of Ctsf Gene (Cln10) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

Pathway Diagram

The following diagram shows the key molecular relationships involving CTSF Gene (CLN10) discovered through SciDEX knowledge graph analysis: